{"id":45358,"date":"2022-06-22T15:02:15","date_gmt":"2022-06-22T13:02:15","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/radiology-partners-names-dr-krishna-nallamshetty-chief-medical-officer\/"},"modified":"2022-06-22T15:02:15","modified_gmt":"2022-06-22T13:02:15","slug":"radiology-partners-names-dr-krishna-nallamshetty-chief-medical-officer","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/radiology-partners-names-dr-krishna-nallamshetty-chief-medical-officer\/","title":{"rendered":"Radiology Partners Names Dr. Krishna Nallamshetty Chief Medical Officer"},"content":{"rendered":"
\n

\nContinued emphasis on elevating radiologists to senior executive leadership roles<\/i><\/b>\n<\/p>\n

EL SEGUNDO, Calif.–(BUSINESS WIRE)–Radiology Partners<\/a> (RP), the leading radiology practice in the U.S., announced today that Dr. Krishna Nallamshetty (@knallamMD<\/a>) has been appointed to serve as the practice\u2019s next Chief Medical Officer (CMO) effective immediately. As a member of RP\u2019s senior leadership team<\/a> Dr. Nallamshetty will champion all aspects of RP\u2019s clinical agenda and ensure patient care, clinical value and physician leadership are effectively integrated and prominently represented within RP\u2019s business strategies.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\n\u201cAs CMO, Dr. Nallamshetty will fulfill an integral executive role within our practice and bring his proven leadership skills and strategic lens to all <\/i>aspects of our business\u2014clinical and otherwise,\u201d said Rich Whitney, RP Chairman and CEO. \u201cAt RP, radiologists are central to our mission of transforming the specialty and positively impacting the entire healthcare system, <\/i>and RP has invested continuously in physician executives who can lead at scale. I couldn\u2019t be more excited to announce the elevation of Dr. Nallamshetty to CMO after several years of demonstrated leadership and his increasingly important impact within our practice.\u201d\n<\/p>\n

\nRP established<\/a> its Office of the Chief Medical Officer in 2021. Today, it comprises 17 radiologists serving in senior executive leadership roles through key portfolios including: operations, integrations, communications and health policy, clinical artificial intelligence, clinical technology and data, radiologist experience, clinical value, research and education, recruitment and growth. As part of his role as CMO, Dr. Nallamshetty will provide ongoing leadership and coordination among this outstanding group of physician leaders.\n<\/p>\n

\n\u201cRP continues to lead our specialty because we are keenly focused on positioning our more than 3,000 radiologists to have a larger impact\u2014both in radiology and in the broader healthcare system\u2014and we are committed to physician leadership at every level of the practice,\u201d said Dr. Nallamshetty. \u201cI am deeply honored to serve as RP\u2019s CMO and will support our engaged physicians and support teammates as they continue to advance our clinical vision, offer superior service to our referring physicians and client partners and provide excellent care for our patients. Together, we are advancing our mission to transform radiology.\u201d\n<\/p>\n

\nAbout Dr. Krishna Nallamshetty<\/b>\n<\/p>\n

\nDr. Nallamshetty joined RP in 2018. He previously served as Practice President for Radiology Associates of Florida (a RP-affiliated practice) and in several national leadership roles for RP, including: Vice Chair of RP\u2019s Presidents Council, member of the Executive Committee of the Presidents Council and member of the Culture and Leadership Development Physician Support Board and the Growth Support Board. In 2020, he was named RP\u2019s Associate CMO for Clinical Value, charged with advancing the practice\u2019s clinical roadmap through development of value-based clinical programs to support patient care outcomes, safety and payor and policy initiatives. He is the Chief of Staff for Tampa General Hospital and was most recently named the Chair of the Department of Radiology at USF Health Morsani College of Medicine. Dr. Nallamshetty is a cardiovascular radiologist and earned his medical degree from Thomas Jefferson University in Philadelphia. He completed his residency in diagnostic imaging at Tufts University School of Medicine and fellowship in Cardiovascular Imaging at Harvard Medical School.\n<\/p>\n

\nAbout Radiology Partners<\/b>\n<\/p>\n

\nRadiology Partners is the largest radiology practice in the U.S., serving more than 3,250 hospitals and other healthcare facilities across the nation. As a physician-led and physician-owned practice, our mission is to transform radiology by innovating across clinical value, technology, service and economics, while elevating the role of radiology and radiologists in healthcare. Using a proven healthcare services model, Radiology Partners provides consistent, high quality care to patients, while delivering enhanced value to the hospitals, clinics, imaging centers and referring physicians we serve. Learn more at radpartners.com<\/a> and connect with us at @Rad_Partners<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nSheila Biggs
\n
sbiggs@jarrardinc.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Continued emphasis on elevating radiologists to senior executive leadership roles EL SEGUNDO, Calif.–(BUSINESS WIRE)–Radiology Partners (RP), the leading radiology practice in the U.S., announced today that Dr. Krishna Nallamshetty (@knallamMD) has been appointed to serve as the practice\u2019s next Chief Medical Officer (CMO) effective immediately. As a member of RP\u2019s senior leadership team Dr. Nallamshetty … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45358","6":"format-standard","7":"category-industry"},"yoast_head":"\nRadiology Partners Names Dr. Krishna Nallamshetty Chief Medical Officer - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/radiology-partners-names-dr-krishna-nallamshetty-chief-medical-officer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Radiology Partners Names Dr. Krishna Nallamshetty Chief Medical Officer - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Continued emphasis on elevating radiologists to senior executive leadership roles EL SEGUNDO, Calif.–(BUSINESS WIRE)–Radiology Partners (RP), the leading radiology practice in the U.S., announced today that Dr. Krishna Nallamshetty (@knallamMD) has been appointed to serve as the practice\u2019s next Chief Medical Officer (CMO) effective immediately. As a member of RP\u2019s senior leadership team Dr. Nallamshetty ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/radiology-partners-names-dr-krishna-nallamshetty-chief-medical-officer\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-22T13:02:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220622005144\/en\/1492950\/21\/Nallamshetty_Prefferred_Headshot.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/radiology-partners-names-dr-krishna-nallamshetty-chief-medical-officer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/radiology-partners-names-dr-krishna-nallamshetty-chief-medical-officer\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Radiology Partners Names Dr. Krishna Nallamshetty Chief Medical Officer\",\"datePublished\":\"2022-06-22T13:02:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/radiology-partners-names-dr-krishna-nallamshetty-chief-medical-officer\\\/\"},\"wordCount\":639,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/radiology-partners-names-dr-krishna-nallamshetty-chief-medical-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220622005144\\\/en\\\/1492950\\\/21\\\/Nallamshetty_Prefferred_Headshot.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/radiology-partners-names-dr-krishna-nallamshetty-chief-medical-officer\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/radiology-partners-names-dr-krishna-nallamshetty-chief-medical-officer\\\/\",\"name\":\"Radiology Partners Names Dr. Krishna Nallamshetty Chief Medical Officer - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/radiology-partners-names-dr-krishna-nallamshetty-chief-medical-officer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/radiology-partners-names-dr-krishna-nallamshetty-chief-medical-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220622005144\\\/en\\\/1492950\\\/21\\\/Nallamshetty_Prefferred_Headshot.jpg\",\"datePublished\":\"2022-06-22T13:02:15+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/radiology-partners-names-dr-krishna-nallamshetty-chief-medical-officer\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/radiology-partners-names-dr-krishna-nallamshetty-chief-medical-officer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/radiology-partners-names-dr-krishna-nallamshetty-chief-medical-officer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220622005144\\\/en\\\/1492950\\\/21\\\/Nallamshetty_Prefferred_Headshot.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220622005144\\\/en\\\/1492950\\\/21\\\/Nallamshetty_Prefferred_Headshot.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/radiology-partners-names-dr-krishna-nallamshetty-chief-medical-officer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Radiology Partners Names Dr. Krishna Nallamshetty Chief Medical Officer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Radiology Partners Names Dr. Krishna Nallamshetty Chief Medical Officer - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/radiology-partners-names-dr-krishna-nallamshetty-chief-medical-officer\/","og_locale":"en_US","og_type":"article","og_title":"Radiology Partners Names Dr. Krishna Nallamshetty Chief Medical Officer - Pharma Trend","og_description":"Continued emphasis on elevating radiologists to senior executive leadership roles EL SEGUNDO, Calif.–(BUSINESS WIRE)–Radiology Partners (RP), the leading radiology practice in the U.S., announced today that Dr. Krishna Nallamshetty (@knallamMD) has been appointed to serve as the practice\u2019s next Chief Medical Officer (CMO) effective immediately. As a member of RP\u2019s senior leadership team Dr. Nallamshetty ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/radiology-partners-names-dr-krishna-nallamshetty-chief-medical-officer\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-22T13:02:15+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220622005144\/en\/1492950\/21\/Nallamshetty_Prefferred_Headshot.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/radiology-partners-names-dr-krishna-nallamshetty-chief-medical-officer\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/radiology-partners-names-dr-krishna-nallamshetty-chief-medical-officer\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Radiology Partners Names Dr. Krishna Nallamshetty Chief Medical Officer","datePublished":"2022-06-22T13:02:15+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/radiology-partners-names-dr-krishna-nallamshetty-chief-medical-officer\/"},"wordCount":639,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/radiology-partners-names-dr-krishna-nallamshetty-chief-medical-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220622005144\/en\/1492950\/21\/Nallamshetty_Prefferred_Headshot.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/radiology-partners-names-dr-krishna-nallamshetty-chief-medical-officer\/","url":"https:\/\/pharma-trend.com\/en\/radiology-partners-names-dr-krishna-nallamshetty-chief-medical-officer\/","name":"Radiology Partners Names Dr. Krishna Nallamshetty Chief Medical Officer - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/radiology-partners-names-dr-krishna-nallamshetty-chief-medical-officer\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/radiology-partners-names-dr-krishna-nallamshetty-chief-medical-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220622005144\/en\/1492950\/21\/Nallamshetty_Prefferred_Headshot.jpg","datePublished":"2022-06-22T13:02:15+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/radiology-partners-names-dr-krishna-nallamshetty-chief-medical-officer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/radiology-partners-names-dr-krishna-nallamshetty-chief-medical-officer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/radiology-partners-names-dr-krishna-nallamshetty-chief-medical-officer\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220622005144\/en\/1492950\/21\/Nallamshetty_Prefferred_Headshot.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220622005144\/en\/1492950\/21\/Nallamshetty_Prefferred_Headshot.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/radiology-partners-names-dr-krishna-nallamshetty-chief-medical-officer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Radiology Partners Names Dr. Krishna Nallamshetty Chief Medical Officer"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45358","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45358"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45358\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45358"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45358"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45358"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}